The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2022 | QoL changes following a lung cancer diagnosis
Matthew Evison, MD, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK, gives an overview of quality of life (QoL) changes a patients with lung cancer may go through following a diagnosis. QoL for the patient may decline due to the physiological burden of receiving a cancer diagnosis, physical symptoms such as breathlessness and long term weight loss, and financial pressures. Dr Evison additionally emphasizes the non-curative nature of surgery, where patients may face long-term issues relating to having lung tissue removed, as well as the need for patients to make long-term fitness improvements as a result of surgery. This interview took place at the 20th Annual British Thoracic Oncology Group (BTOG) Conference 2022.
